U.S. Trade Distributors Stock News

Cboe Global Markets appointed Julie Bauer as Senior Vice President, Head of Government Relations. The new role focuses on global advocacy and regulatory engagement with policymakers and market supervisors. The appointment introduces an experienced policy executive at a time of complex regulatory scrutiny for market infrastructure firms. Cboe Global Markets, ticker BATS:CBOE, is drawing attention after naming Julie Bauer to lead its government relations efforts. The move comes with the stock...

GDS Holdings (GDS) is back on traders’ radar after a sharp share price move tied to improved analyst sentiment, a stronger earnings outlook and renewed AI driven growth in its China data center business. See our latest analysis for GDS Holdings. The recent 6.9% 1 day share price return and 9.4% 30 day share price return come on top of a 19.2% year to date share price return. At the same time, the 1 year total shareholder return of 67.46% and very large 3 year total shareholder return of about...

Fortinet and NVIDIA have announced FortiAIGate, a GPU accelerated zero trust security platform focused on protecting AI workloads, data, and autonomous agents. The joint solution is aimed at securing AI deployments across data centers, cloud, and edge environments, with features tailored to AI specific risks such as prompt injection attacks. Fortinet, traded as NasdaqGS:FTNT, is drawing fresh attention with this move into AI focused security infrastructure. The stock recently closed at...

In recent weeks, Ionis Pharmaceuticals announced that the FDA accepted its priority review submissions for olezarsen in severe hypertriglyceridemia and zilganersen in neurology, while the company ramped up launch preparations for both therapies. These regulatory milestones mark an important shift as Ionis moves further into independent commercialization, potentially broadening its treatment footprint beyond rare disease niches. Now, we’ll examine how FDA priority review for olezarsen and...

Amdocs recently reported past quarterly results showing revenue and earnings largely in line with guidance while unveiling new AI‑driven platforms and confirming a CFO transition effective June 1, 2026. At the same time, the company deepened its role in telecom modernization through multi‑year agreements and cloud migrations with operators such as Telefónica Móviles Argentina, Vodafone Ireland, Lumen Technologies, and others. Next, we’ll examine how Amdocs’ push into AI-powered telco...

Targa Resources (TRGP) is back in focus after first quarter 2026 results showed revenue of US$4,094.7 million and net income of US$479.6 million, alongside commentary highlighting Permian growth potential and extensive midstream infrastructure. See our latest analysis for Targa Resources. The first quarter earnings, together with ongoing share repurchases of US$696.92 million since August 2024, come against a strong backdrop, with a 30 day share price return of 9.47% and a one year total...

Fourth quarter earnings put GSI Technology’s recent stock move in context GSI Technology (GSIT) recently reported fourth quarter results, with sales of US$6.32 million and a net loss of US$4.82 million, drawing fresh attention to a stock that has already seen strong recent returns. See our latest analysis for GSI Technology. The earnings release has landed against a backdrop of very strong recent momentum, with a 30 day share price return of 98.30% and a 1 year total shareholder return of...

Investors may be wondering if Newmont at US$118.96 is still reasonably priced after a strong run, or if the easy gains are behind it. The stock has recent returns of 3.4% over 7 days, 2.1% over 30 days, 17.5% year to date, 147.6% over 1 year and 186.2% over 3 years, which naturally puts the spotlight on whether the current price reflects these moves. Recent discussion around Newmont has focused on how the stock fits into broader materials sector themes and how investors are thinking about...

Cava Group recently saw increased attention ahead of its past May 19 earnings release, with analysts projecting higher revenue but lower year-over-year earnings per share alongside brisk options trading that pointed to a potentially sharp post-report price move. Insider share sales tied to vested restricted stock units and rising analyst earnings estimates highlighted how tax-driven transactions and shifting expectations can both influence how investors interpret the company’s growth and...

American Eagle Outfitters (NYSE:AEO) and Bubble Skincare are launching a co-created collection that combines apparel and skincare. The partnership brings a shared focus on community-driven values and Gen Z engagement into a single product line. The collection will be available across American Eagle stores, online, and through TikTok Shop, including a first-time rollout for the company on that platform. For investors watching NYSE:AEO, this collaboration sits at the intersection of fashion,...

Formula One Group recently reported past first-quarter 2026 results, with revenue of US$711 million and net income of US$57 million, both sharply higher than a year earlier. The strong year-on-year jump in profitability suggests the business is converting its growing commercial footprint and content portfolio into meaningfully improved earnings power. Next, we’ll examine how this earnings acceleration, particularly the jump in net income, affects Formula One Group’s broader investment...

SiTime (SITM) just paired strong first quarter 2026 results with a new AI focused timing chip, the Elite 2 Super-TCXO, putting both its earnings profile and AI data center opportunity in sharper focus for investors. See our latest analysis for SiTime. The stock’s recent surge has been sharp, with a 30 day share price return of 86.84% and a year to date share price return of 125.78%. The 1 year total shareholder return of 311.48% and 5 year total shareholder return near 9x underline how much...

Recent attention on Zevra Therapeutics (ZVRA) centers on its first quarter 2026 earnings, where sales and net income figures shifted sharply, and earnings per share turned positive compared with a loss a year earlier. See our latest analysis for Zevra Therapeutics. Those earnings and the recent SDX portfolio sale have come alongside a 30 day share price return of 14.4% and a 90 day share price return of 32.38%, while the 3 year total shareholder return of 127.4% points to momentum that has...

Etsy, NYSE:ETSY, is seeing intensifying competition that is linked to declining buyer activity. The company has reported an annual decline in active buyers and is projecting a sales contraction over the next year. Flat earnings growth alongside higher revenues has raised questions about Etsy's ability to turn demand into stronger profitability. Etsy, NYSE:ETSY, is coming under pressure as buyer activity softens, adding a new layer of risk for a stock that has already been volatile. Shares...

Maravai LifeSciences Holdings (NasdaqGS:MRVI) reported a 41% jump in Q1 2026 revenue. The company sharply narrowed its net loss and posted positive Adjusted EBITDA in the quarter. Results were supported by a large CleanCap vaccine order and meaningful debt reduction. For investors following NasdaqGS:MRVI, this Q1 2026 update marks a clear break from recent coverage that focused on ongoing losses and softer growth. The stock is trading at $4.37, with the share price up 10.9% over the past...

Flutter Entertainment (NYSE:FLUT) is back in focus after trimming its fiscal 2026 outlook and reporting first quarter results that combined strong sales with lower net income, along with leadership changes at core brand FanDuel. See our latest analysis for Flutter Entertainment. Those first quarter results, the trimmed 2026 outlook and leadership changes at FanDuel have come alongside a sharp reset in sentiment, with the share price down 56% year to date and the 1 year total shareholder...

Wondering if Brown-Forman's current share price reflects its true worth, or if the stock might be mispriced based on fundamentals and market expectations. The stock last closed at US$26.16, with returns that were roughly flat year to date at 0.1%, but with declines of 3.0% over the past week, 10.6% over the past month, and 22.4% over the past year, and 55.8% and 62.8% over the past 3 and 5 years respectively. These changes may affect how you think about both risk and potential future...

On April 30, 2026, Best Buy disclosed that two shareholder groups filed proposals asking for detailed reporting on risks tied to ESG and DEI-linked executive pay and on the financial rationale for investments highlighted in its 2025 Corporate Responsibility & Sustainability Report, while the company urged investors to vote against both at its upcoming June 12, 2026 meeting. This clash over ESG oversight and investment transparency highlights growing tension between activist shareholders...

If you are wondering whether Fluence Energy's current share price still offers value after a strong run, the numbers around recent performance and valuation checks are worth a closer look. The stock trades at US$22.10, with returns of 63.0% over the past week, 61.9% over the past month, a decline of 4.0% year to date, and 305.5% over the last year. This naturally raises questions about how much upside or risk is now priced in. Recent coverage has focused on Fluence Energy's role in energy...

Brunswick (NYSE:BC) is supplying marine platforms, propulsion and electronics for Textron Systems’ TSUNAMI uncrewed surface vessel fleet. The partnership focuses on modular, scalable systems designed for autonomy and defense applications for the U.S. Navy. This agreement extends Brunswick’s marine technology beyond recreational boating into dual use military programs. For investors watching NYSE:BC, this defense collaboration adds a new angle to a company better known for recreational...

TG Therapeutics recently reported past first-quarter 2026 results showing revenue of US$204.92 million and net income of US$19.78 million, while raising its full-year 2026 total global revenue target to about US$925 million, largely driven by higher expected BRIUMVI U.S. net product revenue of US$885 million to US$900 million. This combination of stronger earnings and higher guidance underlines how central BRIUMVI has become to TG Therapeutics’ business model and forward planning. We’ll now...

Insmed (INSM) has drawn fresh investor attention after reporting first quarter 2026 results that combined significant revenue contributions from BRINSUPRI and ARIKAYCE with a smaller net loss and reiterated full year guidance. See our latest analysis for Insmed. Despite the solid Q1 update and reiterated guidance, the stock has recently pulled back, with a 30 day share price return of down 21.93% and a year to date share price return of down 33.38%. At the same time, the 1 year total...

LendingClub (NYSE:LC) is rebranding as Happen Bank to reflect its technology focused banking model. The company is shifting its business toward serving institutional loan buyers rather than individual peer to peer investors. Happen Bank is expanding into home improvement lending, with plans to add home equity and mortgage products over time. For you as an investor, the Happen Bank rebrand marks a clear break from LendingClub's peer to peer roots and leans into its role as a digital bank...

Molina Healthcare and The MolinaCares Accord announced a new grant to support an empowerment and skills program for young adults with disabilities in Massachusetts. The initiative funds the Youth Empowerment Services, or YES, program, focused on building employment readiness and independence. The program targets young adults with disabilities and is positioned as a community-focused extension of Molina Healthcare's existing services. For investors watching NYSE:MOH, this new grant adds a...